🇧🇪
Sector: Life Sciences
Fund: Fund II
Team: Attila BorbĂĄth, Pascal Doguet

Description

Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform.

By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies.

Full range of applications
Synergia Medical’s technology could benefit numerous neurological diseases such as chronic pain, Parkinson’s disease, drug-resistant epilepsy, sleep apnoea and depression.

Synergia Medical’s current IP portfolio includes non-metallic encapsulation of neurostimulators, fast-charging wireless system, a custom optical lead, miniaturized photovoltaic cells and an enhanced electrode.

Company News

Neurotech: Synergia Exploits Optoelectronics for Neuromodulation

Neurotech: Synergia Exploits Optoelectronics for Neuromodulation

Read more

Une première mondiale belge : des implants contre l’ĂŠpilepsie activĂŠs par la lumière

Une première mondiale belge : des implants contre l’ĂŠpilepsie activĂŠs par la lumière

Read more

Synergia Medical Successfully Implants First Patients with NAO.VNS™

Synergia Medical Successfully Implants First Patients with NAO.VNS™

Read more

SYNERGIA published in NATURE: An optoelectronic implantable neurostimulation platform allowing full MRI safety and optical sensing and communication

SYNERGIA published in NATURE: An optoelectronic implantable neurostimulation platform allowing full MRI safety and optical sensing and communication

Read more

Investment Managers

Other investments in Life Sciences

Other investments in Fund II

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

Newsletter Form (#56)